- Page 1 and 2: Pharmaceutical Compounding and Disp
- Page 4 and 5: Pharmaceutical Compounding and Disp
- Page 6: Contents Introduction to the FASTtr
- Page 9 and 10: viii Preface This book has been wri
- Page 12 and 13: chapter 1 Introduction Layout of th
- Page 14 and 15: Storage and labelling requirements
- Page 16 and 17: Appearance Correct position - Medi
- Page 18 and 19: intended for internal use, this is
- Page 20 and 21: pharmaceutical dosage forms. As it
- Page 22 and 23: Medical bottles Plain amber medicin
- Page 26 and 27: scale manufacturing environments wh
- Page 28 and 29: chapter 2 Solutions Overview Upon c
- Page 30 and 31: Figure 2.1 A porcelain mortar and p
- Page 32 and 33: The following method would be used
- Page 34 and 35: measure and add to the Sodium Bicar
- Page 36 and 37: d. Flavouring when appropriate Liqu
- Page 38 and 39: 1. Use of the product Used as a mou
- Page 40 and 41: The fi nal volume of Sodium Chlorid
- Page 42 and 43: Patient: Mr Gary Murray, 12 Bishop
- Page 44 and 45: c. Product-specifi c cautions (or a
- Page 46 and 47: Solutions 4. A paediatric vitamin d
- Page 48 and 49: 13. How much solid would be require
- Page 50 and 51: Questions 23. How many millilitres
- Page 52 and 53: Solutions 31. The molecular weight
- Page 54 and 55: chapter 3 Suspensions Overview Upon
- Page 56 and 57: 3. Prepare any Double Strength Chlo
- Page 58 and 59: 2. Is it safe and suitable for the
- Page 60 and 61: ensure that only the correct amount
- Page 62 and 63: Example 3.2 The preparation of Paed
- Page 64 and 65: 9. Add the Syrup BP to the mortar a
- Page 66 and 67: Product formula (from the British P
- Page 68 and 69: 7. Advice to patient The patient wo
- Page 70 and 71: 5. Transfer the tablets to a glass
- Page 72 and 73: Self-assessment Questions 1. Distin
- Page 74:
Formulation questions This section
- Page 77 and 78:
66 Pharmaceutical Compounding and D
- Page 79 and 80:
68 Pharmaceutical Compounding and D
- Page 81 and 82:
70 Pharmaceutical Compounding and D
- Page 83 and 84:
72 Pharmaceutical Compounding and D
- Page 85 and 86:
74 Pharmaceutical Compounding and D
- Page 87 and 88:
76 Pharmaceutical Compounding and D
- Page 89 and 90:
78 Pharmaceutical Compounding and D
- Page 91 and 92:
80 Pharmaceutical Compounding and D
- Page 93 and 94:
82 Pharmaceutical Compounding and D
- Page 95 and 96:
84 Pharmaceutical Compounding and D
- Page 97 and 98:
86 Pharmaceutical Compounding and D
- Page 99 and 100:
88 Pharmaceutical Compounding and D
- Page 102 and 103:
chapter 5 Creams Overview Upon comp
- Page 104 and 105:
Figure 5.1 A water bath and heater.
- Page 106 and 107:
Worked examples Example 5.1 The pre
- Page 108 and 109:
. Quantitative particulars Quantita
- Page 110 and 111:
5. Choice of container A collapsibl
- Page 112 and 113:
Product formula Master 100 g 10 g 6
- Page 114 and 115:
3. How many grams of Eumovate Cream
- Page 116:
13. You receive a prescription in y
- Page 119 and 120:
108 Pharmaceutical Compounding and
- Page 121 and 122:
110 Pharmaceutical Compounding and
- Page 123 and 124:
112 Pharmaceutical Compounding and
- Page 125 and 126:
114 Pharmaceutical Compounding and
- Page 127 and 128:
116 Pharmaceutical Compounding and
- Page 129 and 130:
118 Pharmaceutical Compounding and
- Page 131 and 132:
120 Pharmaceutical Compounding and
- Page 133 and 134:
122 Pharmaceutical Compounding and
- Page 135 and 136:
124 Pharmaceutical Compounding and
- Page 137 and 138:
126 Pharmaceutical Compounding and
- Page 139 and 140:
128 Pharmaceutical Compounding and
- Page 141 and 142:
130 Pharmaceutical Compounding and
- Page 143 and 144:
132 Pharmaceutical Compounding and
- Page 146 and 147:
chapter 7 Suppositories and pessari
- Page 148 and 149:
Worked examples Example 7.1 Calibra
- Page 150 and 151:
Patient: Master Roger Carlson, 21 H
- Page 152 and 153:
Suppositories BP as they are availa
- Page 154 and 155:
Method of preparation of Ichthammol
- Page 156 and 157:
Bismuth Subgallate BP displaces 2
- Page 158 and 159:
f. Discard date The products are su
- Page 160:
8. You receive a prescription in yo
- Page 163 and 164:
152 Pharmaceutical Compounding and
- Page 165 and 166:
154 Pharmaceutical Compounding and
- Page 167 and 168:
156 Pharmaceutical Compounding and
- Page 169 and 170:
158 Pharmaceutical Compounding and
- Page 171 and 172:
160 Pharmaceutical Compounding and
- Page 173 and 174:
162 Pharmaceutical Compounding and
- Page 175 and 176:
164 Pharmaceutical Compounding and
- Page 178 and 179:
Answers to self-assessment Chapter
- Page 180 and 181:
Answers to self-assessment 29. 1 li
- Page 182 and 183:
Answers to self-assessment 34. Hibi
- Page 184 and 185:
Answers to self-assessment 9. Quant
- Page 186 and 187:
Answers to self-assessment dissolut
- Page 188 and 189:
Answers to self-assessment The foll
- Page 190 and 191:
12. Peppermint Oil BP is a volatile
- Page 192 and 193:
Answers to self-assessment 11. Make
- Page 194 and 195:
Answers to self-assessment Chlorofo
- Page 196 and 197:
9. Answer: d (‘Apply liberally as
- Page 198 and 199:
the same/similar proportions (Briti
- Page 200 and 201:
Answers to self-assessment 9. Answe
- Page 202 and 203:
Answers to self-assessment 1. Weigh
- Page 204 and 205:
Formula For 1 suppository For 10 su
- Page 206 and 207:
Calculations Six suppositories are
- Page 208 and 209:
5. The prescription requests two ca
- Page 210 and 211:
. Quantitative particulars are requ
- Page 212 and 213:
Bibliography British National Formu
- Page 214 and 215:
Appendices Appendix 1 Glossary of t
- Page 216 and 217:
Powder A preparation consisting of
- Page 218 and 219:
pess pessus pessary pig pigmentum a
- Page 220 and 221:
Index abbreviations, 205-7 Acacia B
- Page 222 and 223:
labelling, 3 preparation, terminolo
- Page 224 and 225:
advantages/disadvantages, 18 basic